PATH
Menu

This document provides answers to frequently asked questions about the Meningitis Vaccine Project, including facts about meningococcal meningitis, the MenAfriVac™ vaccine, and next steps for the project.

Corporate author(s): PATH, World Health Organization

Publication date: July 2011

Available materials

English

The Meningitis Vaccine Project: Frequently Asked Questions

236 KB PDF

Hard copies are not available.

French

The Meningitis Vaccine Project: Frequently Asked Questions [French]

313 KB PDF

Also known as: Projet Vaccins Méningite : Foire aux Questions

Ce document répond à des questions souvent posées à propos du Projet Vaccin Méningite, de la méningococcie, du vaccin MenAfriVac™ et du futur du projet. [Hard copies are not available.]

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Africa

See also: Vaccines and immunizationMeningitis

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA